Cellular pH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1194-1198

  Gerweck, Leo E ^a   Seetharaman, Kala ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RESEARCH; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; PH MEASUREMENT; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BRAIN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CELL MEMBRANE; GLIOBLASTOMA; HUMANS; HYDROGEN-ION CONCENTRATION; MICROELECTRODES; NEOPLASMS;

EID: 0029971428     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wike-Hooley, J L., Haveman J., and Reinhold, H. S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol., 2: 343-366, 1984
2. Song, C. W., Lyons, J. C , and Luo, Y Intra- and extracellular pH in solid tumors. influence on therapeutic response. In: B. A. Teicher (ed.), Drug Resistance in Oncology New York: Marcel Dekker, Inc., 1993.
3. Newell, K. J., and Tannock, I F Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazone. Cancer Res., 49: 4477-4482, 1989
4. Tannock I. F., and Rotin, D. Acid pH in tumors and its potential for therapeutic exploitation Cancer Res , 49: 4373-4384, 1989.
5. 31P-NMR. Influence of factors other than pH on 31P chemical shifts. Biochemistry, 20: 5389-5392, 1981.
6. Sijens, P. E., Wijrdeman, H K., Moerland, M A., Bakker, C. J G , Vermeulen, J. W. A. H., and Luyten, P R Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 15 T. Radiology, 169: 615-620, 1988.
7. Oberhaensli, R. D., Bore, P. J., Rampling, R. P , Hilton-Jones, D., Hands, L. J., and Radda, G K. Biochemical investigation of human tumours in vivo with phosphorous-31 magnetic resonance spectroscopy. Lancet I. 811, 1986.
8. Ng, T. C., Majors, A. W., Vijayakumar, S., Baldwin, N. J., Thomas, F. J., Koumoundouros, I , Taylor, M. E , Grundfest, S. F., Meaney, T. F., Tubbs, R R., and Shin, K. H. Human neoplasm pH and response to radiation therapy P-31 MR spectroscopy studies in situ. Radiology, 170: 875-878, 1989
9. Semmler, W., Gademann, G , Bachert-Baumann, P., Zabel, H. J., Lorenz, W. J., and van Kaick, G Monitoring human tumor response to therapy by means of P-31 MR spectroscopy Radiology, 166: 533-539, 1988
10. Nidecker, A C , Muller, S., Aue, W P , Seelig, J., Fridrich, R., Remagen, W , Hartweg, H , and Benz, U. Extremity bone tumors: evaluation by P-31 MR spectroscopy. Radiology, 157: 167-174, 1985.
11. Dewhirst, M. W , Sostman, H. D., Leopold, K. A., Charles, H. C., Moore, D., Burn, R. A., Tucker J. A., Harrelson, J. M., and Oleson, J R. Soft-tissue sarcomas: MR imaging and MR spectroscopy for prognosis and therapy monitoring. Radiology, 174: 847-853, 1990
12. Sostman, H. D , Charles, H. C., Rockwell, S., Leopold, K., Beam, C., Madwed, D , Dewhirst, M., Cofer, G., Moore, D., Burn, R., and Oleson, J. Soft-tissue sarcomas: detection of metabolic heterogeneity with P-31 MR spectroscopy. Radiology, 176: 837-843, 1990.
13. Sostman, H. D , Prescott, D. M., Dewhirst, M. W , Dodge, R. K , Thrall, D. E., Page, R. L., Tucker, J. A., Harrelson, J. M., Reece, G., Leopold, K. A., Oleson, J. R., and Charles, H. C MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. Radiology, 190: 269-275, 1994
14. Hubesch, B., Sappey-Marinier, D , Roth, K., Meyerhoff, D. J., Matson, G. B., and Weiner, M. W. P-31 MR spectroscopy of normal human brain and brain tumors. Radiology, 174: 401-409, 1990.
15. 31P magnetic resonance spectroscopy. Br. J. Cancer, 61: 485-490, 1990.
16. Vaupel, P , Kallinowski, F., and Okunieff, P Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res , 49: 6449-6465, 1989.
17. Wike-Hooley, J., van den Berg, A. P., van der Zee, J , and Reinhold, H. S. Human tumour pH and its variation. Eur. J. Cancer Clin. Oncol., 21. 785-791, 1985.
18. Engin, K., Leeper, D. B., Cater, J R., Thistlethwaite, A. J., Tupchong, L., and McFarlane, J. D. Extracellular pH distribution in human tumours Int J. Hyperthermia, 11: 211-216, 1995.
19. van den Berg, A. P. Wike-Hooley, J. L. van den Berg-Blok, A. E., van der Zee, J., and Reinhold, H. S. Tumour pH in human mammary carcinoma. Eur. J. Cancer Clin. Oncol., 18: 457-462, 1982.
20. Stamm, O , Latscha, U , Janecek, P., and Campana, A. Development of a special electrode for continuous subcutaneous pH measurement in the infant scalp. Am. J. Obstet. Gynecol., 124: 193-195, 1976
21. Vidyasagar, D., Bhat, R., Raju, T. N. K., Asonye, U., and Papazafiratou, C. Continuous tissue pH (tph) monitoring in sick neonates. Pediatr. Res., 13. 509, 1979.
22. Harrison, O. K., and Walker, D. F Microelectrode measurement of skin pH in humans during ischemia, hypoxia and local hyperthermia. J. Physiol. (Lond.), 291: 339-350, 1979
23. Pampus, F. Die Wasserstoffionenkonzentration des Hirngewebes bei raumfordernden intracraniellen Prozessen. Acta Neurochir., 11: 305-318, 1963.
24. Naeslund, J., and Swenson, K. E. Investigations on the pH of malignant tumours in mice and humans after the administration of glucose. Acta Obstet. Gynecol. Scand., 32: 359-367, 1953.
25. Ashby, B S., and Cantab, M. B. pH studies in human malignant tumours. Lancet, 1: 312-315, 1966.
26. Crone, C., and Levitt, D. G. Capillary permeability to small solutes. In: E M. Renkinand and C. C Michel (eds.), Handbook of Physiology - The Cardiovascular System IV, Vol. 4, pp. 411-466. Bethesda, MD. American Physiological Society, 1984.
27. Jain, R. K., and Baxter, L. T. Extravasation and interstitial transport in tumors. In: K. L. Audus and R. J. Raub (eds), Biological Barriers to Protein Delivery, pp. 441-465. New York. Plenum Press, 1993.
28. Goldman, I D. Pharmacokinetics of antineoplastic agents at the cellular level. In: B. Chabner (ed.), Pharmacalogic Principles of Cancer Treatment, pp. 15-44. Philadelphia: W B. Saunders, 1982.
29. Roos, A., and Boron, W. F. Intracellular pH. Physiol. Rev. 61: 296-434, 1981.
30. Mikkelsen, R. B., Asher, C., and Hicks, T. Extracellular pH transmembrane distribution and cytotoxicity of chlorambucil. Biochem. Pharmacol., 34. 2531-2534, 1985
31. Dennis, M. F., Stratford, M. R. L., Wardman, P., and Watts, M. E. Cellular uptake of misonidazole and analogues with acidic or basic functions. Int. J. Radiat Biol., 47: 629-643, 1985.
32. Madden, T. D., Harrigan, P. R., Tai, L C L , Bally, M. B., Mayer, L. D., Redelmeier, T. E., Loughrey, H. C., Tilcock, C P. S., Reinish, L. W., and Cullis, P. R. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient. a survey. Chem. Phys. Lipids, 53: 37-46, 1990.
33. Kallinowski, F., and Vaupel, P. pH distribution in spontaneous and isotransplanted rat tumors. Br. J. Cancer, 38: 314-321, 1989.
34. Martin, R. G., and Jain, R. R. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res., 54: 5670-5674, 1994.
35. Jensen, P. B , Sorensen, B. S., Sehested, M., Grue, P., Demant, E J. F., and Hansen, H. H. Targeting the cytotoxicity of topoisomerase II-directed epipodopllotoxins to tumor cells in acidic environments. Cancer Res., 54. 2659-2963, 1994.
36. Gerweck, L. E., Rhee, J. G., Koutcher, J. A., Song, C. W., and Urano, M. Regulation of pH in murine tumor and muscle. Radiat. Res., 126: 206-209, 1991.
37. 31P MRS as a method of measuring pH in rat tumors. NMR Biomed., 5: 351-359, 1992.
38. 31P magnetic resonance spectroscopy in murine tumors. Br. J. Cancer, 72: 905-911, 1995.